UNC at Chapel Hill — Chapel Hill, North Carolina

UNC at Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Clinical Trials Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

UNC at Chapel Hill has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Atherosclerosis, Stroke, Carotid Stenosis.

Sponsors: Rutgers, The State University of New Jersey, VistaPharm, Inc., Neurogene Inc..

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UNC at Chapel Hill?

UNC at Chapel Hill has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UNC at Chapel Hill conducted?

UNC at Chapel Hill has 8 clinical trials on record, with 1 currently active. Their work covers Atherosclerosis, Stroke, Carotid Stenosis.

Is UNC at Chapel Hill accredited by Crixeo Clinical Trials?

UNC at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UNC at Chapel Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.